A Pilot Study for the Feasibility of F-18 FLT-PET in Locally Advanced Breast Cancer: Comparison with F-18 FDG-PET

Jai-Hyuen LEE; Euy-Nyong KIM; Il-Ki HONG; Jin-Hee AHN; Sung-Bae KIM; Sei-Hyun AHN; Gyung-Yup GONG; Jae-Seung KIM; Seung-Jun OH; Dae-Hyuk MOON; Jin-Sook RYU.
Nuclear Medicine and Molecular Imaging ; : 29-38, 2008.
Artículo en Ko | WPRIM | ID: wpr-223059

Documentos relacionados

  1. Development and validation of a clinicoradiomic nomogram to assess the HER2 status of patients with invasive ductal carcinoma.
  2. The Role of Cryoablation in Breast Cancer Beyond the Oncologic Control: COST and Breast-Q Patient-Reported Outcomes.
  3. Point-of-care devices based on fluorescence imaging and spectroscopy for tumor margin detection during breast cancer surgery: Towards breast conservation treatment.
  4. Toward AI-supported US Triage of Women with Palpable Breast Lumps in a Low-Resource Setting.
  5. [Invasive Ductal Carcinoma within a Borderline Malignancy Phyllodes Tumor-A Case Report].
  6. [A Case of Bilateral HER2-Positive Invasive Ductal Carcinoma with Complete Response on One Side with Trastuzumab Deruxtecan].
  7. [A Case of De Novo Stage Ⅳ Breast Cancer with Umbilical Metastasis and Peritoneal Dissemination].
  8. A bioinformatics analysis of the clinicopathological and prognostic significance of <i>FAM64A</i> mRNA expression in gynecological cancers.
  9. Elevated splenic 18F-fluorodeoxyglucose positron emission tomography/computed tomography activity is associated with 5-year risk of recurrence in non-metastatic invasive ductal carcinoma of the breast.
  10. Non-invasive ductal carcinoma within malignant phyllodes tumor of the breast.